|
Celcuity Inc. (CELC) DCF Valoración
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Celcuity Inc. (CELC) Bundle
¿Busca calcular el valor intrínseco de Celcuity Inc.? Nuestra calculadora CELC DCF integra datos del mundo real con extensas características de personalización, lo que le permite ajustar las proyecciones y mejorar sus estrategias de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -7.5 | -9.2 | -28.1 | -39.2 | -58.3 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .3 | .4 | .3 | .2 | .1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -7.8 | -9.6 | -28.4 | -39.4 | -58.5 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 18.7 | 11.6 | 84.3 | 168.6 | 180.6 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .2 | .2 | .3 | .0 | .8 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | -.2 | -.2 | -.3 | -.2 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .1 | .2 | 1.5 | 2.6 | 5.1 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.4 | -.1 | -.1 | -.2 | -.1 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -7.4 | -9.2 | -29.3 | -40.3 | -58.5 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -7.3 | -8.8 | -27.8 | -39.0 | -57.0 | -4.3 | .0 | .0 | .0 | .0 |
| WACC, % | 7.62 | 7.63 | 7.64 | 7.64 | 7.64 | 7.64 | 7.64 | 7.64 | 7.64 | 7.64 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -4.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -4 | |||||||||
| Net Debt | 7 | |||||||||
| Equity Value | -11 | |||||||||
| Diluted Shares Outstanding, MM | 24 | |||||||||
| Equity Value Per Share | -0.45 |
What You Will Receive
- Pre-Populated Financial Model: Celcuity Inc.’s actual data facilitates accurate DCF valuation.
- Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential metrics.
- Real-Time Calculations: Automatic updates provide immediate feedback as you adjust inputs.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
- Flexible and Reusable: Designed for adaptability, allowing for repeated use in detailed forecasting.
Key Features
- Comprehensive CELC Data: Pre-loaded with Celcuity Inc.'s historical performance and future projections.
- Customizable Assumptions: Modify growth rates, profit margins, discount rates, tax assumptions, and capital investments.
- Interactive Valuation Framework: Real-time updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
- Intuitive User Interface: Designed for ease of use, catering to both industry professionals and newcomers.
How It Works
- Download: Obtain the ready-to-use Excel file featuring Celcuity Inc.'s (CELC) financial metrics.
- Customize: Tailor forecasts, including revenue projections, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate multiple projections and evaluate results immediately.
- Make Decisions: Utilize the valuation insights to inform your investment approach.
Why Choose This Calculator for Celcuity Inc. (CELC)?
- Designed for Experts: A sophisticated tool utilized by analysts, CFOs, and industry consultants.
- Comprehensive Data: Celcuity’s historical and projected financials preloaded for precise analysis.
- Flexible Scenario Analysis: Easily simulate various forecasts and assumptions.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance to help you navigate the process effortlessly.
Who Should Use This Product?
- Investors: Evaluate Celcuity Inc.’s (CELC) market performance before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts for Celcuity Inc. (CELC).
- Startup Founders: Understand how emerging biotech companies like Celcuity Inc. (CELC) are valued in the market.
- Consultants: Create detailed valuation analyses and reports for clients focusing on Celcuity Inc. (CELC).
- Students and Educators: Utilize real-time data from Celcuity Inc. (CELC) to enhance learning in valuation practices.
What the Template Contains
- Pre-Filled DCF Model: Celcuity Inc.’s (CELC) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Celcuity Inc.’s (CELC) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.